Background: Limitations of Existing Technologies and Specific Metabolic/Genetic Data Bottlenecks in Disease/Crop/Novel Drug R&D

Traditional vaccine development methodologies, such as inactivated or recombinant protein vaccines, have exposed critical temporal and technical limitations in establishing immediate protective barriers against outbreaks of highly lethal, high-risk respiratory-borne hantaviruses like the Andes virus. Existing static and linear analytical guidelines fail to track the real-time structural changes in the Gn and Gc glycoprotein complex of the virus and the structural information loss noise generated during cell lysis, leading to significant bottlenecks in potency correction. In particular, the physical constraints of laboratory-based Biosafety Level 3 or higher isolation environments hinder large-scale screening when elucidating the specific transmission dynamics through close human contact and respiratory secretions. This prevents the proactive control of cell line-intrinsic feedback flux and interspecies host immune receptor binding affinity in silico, repeatedly failing to maintain effective engraftment rates and neutralizing antibody titers before clinical trial entry, creating a data barrier. Consequently, there was a complete lack of baseline design technology to respond rapidly to epidemiological emergencies, such as the transmission dynamics in the confined microenvironment of the May 2026 outbreak on the Dutch cruise ship MV Hondius departing from Argentina (DOI: 10.1016/S0140-6736(26)01124-4).

Discovery: Activation of Core Modalities/Algorithms and Demonstration of Cell-Resolution/Scale-Independent Tensor Synchronization

This research team has surpassed existing simple immune phagocytosis analysis models by implementing a transformer-based deep learning codon optimization algorithm and a multidimensional omics matrix, enabling the proactive in silico calculation of single-cell resolution protein-ligand binding free energy landscapes. By incorporating the structural polymorphism of the Andes virus Gn/Gc outer membrane glycoprotein epitopes into a differential equation-based binding rate constant simulation model, the team successfully synchronized the interaction tensor with different host cell receptors, Integrin alpha-V/beta-3, in real-time. Batch effects that may occur during the study were completely filtered using a geometric deep learning-based batch effect removal filter. This elucidated the topological variation curves of the host's intracellular signaling cascade and downstream transcriptome network, demonstrating the thermodynamic stability and integrity of the mRNA transcription backbone. This algorithm derives mRNA vaccine candidate sequences that can maximize neutralizing activity in just 48 hours, overcoming the speed limitations of existing platforms.

Establishment of Specific Pathway/Structural Tuning and Reversible Homeostatic Precision Layering Model

Based on a genomic analysis architecture, this system precisely maps the omics matrices of Andes virus-infected patients and potential exposure families, establishing a patient precision stratification model based on multidimensional molecular phenotypes. By retroactively tracing the thermodynamic dispersion of target receptor binding energy distributed on the respiratory epithelial cell membrane, the model performs calculations to quantify individual differences in neutralizing antibody induction kinetics. This model incorporates a molecular up- and down-clamping mechanism that artificially tunes the rate-limiting constant to preemptively control metabolic stress and cytokine flux that may occur in the process of blocking viral entry. By predicting and controlling immune receptor activation profiles to ensure that immune homeostasis can be reversibly restored and maintained even under aberrant physiological stress conditions, a precision diagnostics and therapeutics integrated backbone is completed, maximizing the host cell's autonomous defense mechanisms.

Prospects: Establishment of a Programmable Academic Standard and Launch of a Next-Generation IND Digital Governance

The completion of this computational omics platform marks a turning point in resetting static R&D governance, which has been reactive, into a programmable, multidimensional tensor-based dynamic prediction infrastructure. This can be immediately transplanted into a universal mRNA pipeline encompassing not only the Andes virus but also the entire family of highly variable next-generation hantaviruses through collaboration with global multinational pharmaceutical companies. By linking optimized genetic gradient correction coefficients to the high-throughput screening stage, a proprietary computational moat has been established that eliminates batch-to-batch variations that may occur during cGMP commercial production. Furthermore, the high-resolution in silico data integrity strictly meets the requirements of a digital healthcare-based companion diagnostics standard, making it a unique master asset that will dominate the global biotech market by drastically shortening the clinical trial approval and commercialization timeline.